EcoDrugPlus

Ribosomal Protein L37

Ensembl ID : ENSMZEG00005002074
Gene Symbol: RPL37
3 Cross references
424 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSMZEG00005011203
Gene Symbol: RPL37A
3 Cross references
420 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSMZEG00005005092
Gene Symbol: RPL38
1 Cross references
194 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSMZEG00005007879
Gene Symbol: RPL39
1 Cross references
146 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSMZEG00005022644
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSMZEG00005004543
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSMZEG00005009965
Gene Symbol: RPL5
4 Cross references
455 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSMZEG00005009924
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSMZEG00005021476
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSMZEG00005003233
Gene Symbol: RPL7A
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSMZEG00005021486
Gene Symbol: RPL8
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSMZEG00005023706
Gene Symbol: RPL9
3 Cross references
509 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).